scispace - formally typeset
Journal ArticleDOI

Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting

TLDR
First-trimester screening combining maternal factors with uterine artery Doppler, blood pressure, and pregnancy-associated plasma protein-A is useful to predict preeclampsia in a routine care setting.
About
This article is published in American Journal of Obstetrics and Gynecology.The article was published on 2013-03-01. It has received 138 citations till now. The article focuses on the topics: Confidence interval.

read more

Citations
More filters
Journal ArticleDOI

Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies

TL;DR: A practical evidence based list of clinical risk factors that can be assessed by a clinician at ≤16 weeks’ gestation to estimate a woman’s risk of pre-eclampsia and the use of aspirin prophylaxis in pregnancy is developed.
Journal ArticleDOI

Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary

TL;DR: The current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy is presented.
Journal ArticleDOI

Early Prediction of Preeclampsia

TL;DR: Effective screening for the development of early onset preeclampsia (PE) can be provided in the first-trimester of pregnancy by a combination of maternal risk factors, uterine artery Doppler, mean arterial pressure, maternal serum pregnancy-associated plasma protein-A, and placental growth factor.
Journal ArticleDOI

Aspirin for Prevention of Preeclampsia

TL;DR: The pharmacodynamics of aspirin, its main effects according to dosage and gestational age, and the evidence-based indications for primary and secondary prevention of preeclampsia are reported.
Journal ArticleDOI

First‐trimester maternal factors and biomarker screening for preeclampsia

TL;DR: It is illustrated that effective screening for the development of early onset PE can be provided in the first‐trimester of pregnancy by a combination of maternal risk factors, mean arterial pressure, uterine artery Doppler, maternal serum pregnancy‐associated plasma protein‐A and placental growth factor.
References
More filters
Journal ArticleDOI

Recommendations for Blood Pressure Measurement in Humans and Experimental Animals Part 1: Blood Pressure Measurement in Humans: A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research

TL;DR: It is increasingly recognized that office measurements correlate poorly with blood pressure measured in other settings, and that they can be supplemented by self-measured readings taken with validated devices at home, which gives a better prediction of risk than office measurements and is useful for diagnosing white-coat hypertension.
Journal ArticleDOI

The Global Impact of Pre-eclampsia and Eclampsia

TL;DR: Although it is a low cost effective treatment, magnesium sulfate is not available in all low and middle income countries; scaling up its use for eClampsia and severe preeclampsia will contribute to achieving the Millennium Development Goals.
Journal ArticleDOI

The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)

TL;DR: The classification and diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP), Vol. 20, No. 1, pp. ix-xiv as mentioned in this paper.
Journal ArticleDOI

Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations

TL;DR: Over the decade studied, the 37 populations in the WHO MONICA Project showed substantial contributions from changes in survival, but the major determinant of decline in CHD mortality is whatever drives changing coronary-event rates.
Related Papers (5)